Celgene's most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $160.00 short call and a strike $170.00 long call offers a potential 13.38% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $160.00 by expiration. The full premium credit of $1.18 would be kept by the premium seller. The risk of $8.82 would be incurred if the stock rose above the $170.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 31.44 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Better Buy: Celgene vs. Starbucks
Thu, 20 Mar 2014 16:01:56 GMT
Is This Why Celgene Can't Catch a Break?
Thu, 20 Mar 2014 14:31:00 GMT
Update from Celgene
Thu, 20 Mar 2014 14:30:05 GMT
First-of-Its-Kind Multinational Survey Confirms Psoriasis and Psoriatic Arthritis Patients Are Frequently Undertreated or Not Treated at All
Thu, 20 Mar 2014 12:00:00 GMT
Business Wire – A unique and extensive survey provides the first-of-its-kind multinational look into the impact psoriasis and psoriatic arthritis have on patients’ lives, revealing several a
Celgene reiterates commitment to improving pancreatic cancer care in Europe
Wed, 19 Mar 2014 09:36:55 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook